1. Oh S, Jung JH, Ahn KJ, et al. Stem cell and exosome therapy in pulmonary hypertension. Korean Circ J. 2022; 52:110–122. PMID:
35128849.
2. von Herbay A, Illes A, Waldherr R, Otto HF. Pulmonary tumor thrombotic microangiopathy with pulmonary hypertension. Cancer. 1990; 66:587–592. PMID:
2163747.
3. Kumar N, Price LC, Montero MA, Dimopoulos K, Wells AU, Wort SJ. Pulmonary tumour thrombotic microangiopathy: unclassifiable pulmonary hypertension? Eur Respir J. 2015; 46:1214–1217. PMID:
26206876.
4. Bak M, Kim M, Lee B, et al. Clinical course of suspected diagnosis of pulmonary tumor thrombotic microangiopathy: a 10-year experience of rapid progressive right ventricular failure syndrome in advanced cancer patients. Korean Circ J. 2023; 53:170–184.
5. Godbole RH, Saggar R, Kamangar N. Pulmonary tumor thrombotic microangiopathy: a systematic review. Pulm Circ. 2019; 9:2045894019851000. PMID:
31032740.
6. Uruga H, Fujii T, Kurosaki A, et al. Pulmonary tumor thrombotic microangiopathy: a clinical analysis of 30 autopsy cases. Intern Med. 2013; 52:1317–1323. PMID:
23774540.
7. Jung MH, Jung HO, Kwon SJ, Chang S. Clinical presentations and multimodal imaging diagnosis in chronic thromboembolic pulmonary hypertension. J Clin Med. 2022; 11:6678. PMID:
36431155.
8. Higo K, Kubota K, Takeda A, Higashi M, Ohishi M. Successful antemortem diagnosis and treatment of pulmonary tumor thrombotic microangiopathy. Intern Med. 2014; 53:2595–2599. PMID:
25400181.
9. Ogawa A, Yamadori I, Matsubara O, Matsubara H. Pulmonary tumor thrombotic microangiopathy with circulatory failure treated with imatinib. Intern Med. 2013; 52:1927–1930. PMID:
23994985.
10. Kubota K, Shinozaki T, Imai Y, Kario K. Imatinib dramatically alleviates pulmonary tumour thrombotic microangiopathy induced by gastric cancer. BMJ Case Rep. 2017; 2017:bcr2017221032.